Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (Q28187904)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

corrigendum / erratum

Erratum: ADDENDUM: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NM0406-479

author

David J. Brooks

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Steven S Gill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Nikunj K Patel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Gary R Hotton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Karen O'Sullivan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Renée McCarter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Martin Bunnage

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Clive N Svendsen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Peter Heywood

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

31 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

589-595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

Treatment interventions for Parkinson's disease: an evidence based assessment

2 November 2019

cites work

1 reference

7 January 2021

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

7 January 2021

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

1 reference

7 January 2021

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

7 January 2021

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

1 reference

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

7 January 2021

Neuroprotective and neurorestorative properties of GDNF.

1 reference

7 January 2021

Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys

1 reference

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

7 January 2021

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

1 reference

7 January 2021

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

1 reference

7 January 2021

Expression of neurturin, GDNF, and their receptors in the adult mouse CNS.

1 reference

7 January 2021

Core assessment program for intracerebral transplantations (CAPIT)

1 reference

7 January 2021

The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease

1 reference

7 January 2021

Cognitive functioning after subthalamic nucleotomy for refractory Parkinson's disease

1 reference

7 January 2021

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease

1 reference

7 January 2021

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

1 reference

7 January 2021

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study

1 reference

7 January 2021

Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys

1 reference

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

7 January 2021

Dyskinesias following neural transplantation in Parkinson's disease

1 reference

7 January 2021

The behavioural and motor consequences of focal lesions of the basal ganglia in man.

1 reference

7 January 2021

Objective changes in motor function during placebo treatment in PD

1 reference

7 January 2021

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease

1 reference

7 January 2021

Clinical observations after neural transplantation in Parkinson's disease

1 reference

7 January 2021

Olfactory threshold in Parkinson's disease

1 reference

7 January 2021

Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology

1 reference

7 January 2021

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

1 reference

7 January 2021

In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF.

1 reference

7 January 2021

Sustained delivery of GDNF: towards a treatment for Parkinson's disease

1 reference

7 January 2021

Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease.

1 reference

7 January 2021

Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons

1 reference

7 January 2021

Nerve growth factor signaling, neuroprotection, and neural repair

1 reference

7 January 2021

Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?

1 reference

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM850

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12669033%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017